An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone.
作者信息
Nam Soo Jeong, Kim Sehui, Paik Jin Ho, Kim Tae Min, Heo Dae Seog, Kim Chul Woo, Jeon Yoon Kyung
机构信息
a Department of Pathology , Seoul National University Hospital, Seoul National University College of Medicine , Seoul , Republic of Korea ;
b The Tumor Immunity Medical Research Center, Cancer Research Center, Seoul National University College of Medicine , Seoul , Republic of Korea ;
出版信息
Leuk Lymphoma. 2016 Aug;57(8):1956-60. doi: 10.3109/10428194.2015.1117610. Epub 2016 Jan 4.
Abstract
摘要
Zotero 插件